{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:33:31Z","timestamp":1785411211691,"version":"3.56.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.ymgme.2010.09.002","type":"journal-article","created":{"date-parts":[[2010,9,17]],"date-time":"2010-09-17T06:48:06Z","timestamp":1284706086000},"page":"41-43","source":"Crossref","is-referenced-by-count":29,"title":["Body composition analysis in late-onset Pompe disease"],"prefix":"10.1016","volume":"102","author":[{"given":"G.K.","family":"Papadimas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Terzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Methenitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Spengos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Vassilopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kavouras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Michelakakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Manta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2010.09.002_bb0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2010.09.002_bb0010","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe's disease","volume":"372","author":"van der Ploeg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2010.09.002_bb0015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/CND.0b013e318176dbe4","article-title":"Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy","volume":"9","author":"Katzin","year":"2008","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"10.1016\/j.ymgme.2010.09.002_bb0020","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.rmed.2008.12.009","article-title":"Pompe disease: a neuromuscular disease with respiratory muscle involvement","volume":"103","author":"Mellies","year":"2009","journal-title":"Respir. Med."},{"key":"10.1016\/j.ymgme.2010.09.002_bb0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid (alpha) glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2010.09.002_bb0030","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1468-1331.2008.02377.x","article-title":"Glycogen storage disease type II (Pompe disease) - influence of enzyme replacement therapy in adults","volume":"16","author":"Merk","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ymgme.2010.09.002_bb0035","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1468-1331.2010.02959.x","article-title":"Changes in nutritional status and body composition during enzyme replacement therapy in adult-onset type II glucogenosis","volume":"17","author":"Ravaglia","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ymgme.2010.09.002_bb0040","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00247-007-0428-y","article-title":"Fractures in children with Pompe disease: a potential long-term complication","volume":"37","author":"Case","year":"2007","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.ymgme.2010.09.002_bb0045","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000013628","article-title":"Renal magnesium wasting, hypomagnesemic hypocalcemia, hypocalciouria, and osteopenia in a patient with glycogenosis type II","volume":"20","author":"Oktenli","year":"2000","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.ymgme.2010.09.002_bb0050","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bone.2010.06.021","article-title":"Low bone mass in Pompe disease. Muscular strength as a predictor of bone mineral density","volume":"47","author":"van den Berg","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.ymgme.2010.09.002_bb0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mus.20665","article-title":"Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy","volume":"35","author":"Slonim","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2010.09.002_bb0060","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF01622200","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group","volume":"4","author":"Kanis","year":"1994","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.ymgme.2010.09.002_bb0065","first-page":"25","article-title":"The effect of muscle dysfunction on bone mass and morphology","volume":"10","author":"Gross","year":"2001","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.ymgme.2010.09.002_bb0070","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/01.gim.0000217789.14470.c5","article-title":"Physical therapy management of Pompe disease","volume":"8","author":"Case","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2010.09.002_bb0075","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.nmd.2008.07.005","article-title":"The relationship between regional body composition and quantitative strength in fascioscapulohumeral muscular dystrophy (FSHD)","volume":"18","author":"Skalsky","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2010.09.002_bb0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/CND.0b013e318183e0fa","volume":"10","author":"Kharti","year":"2008","journal-title":"J. Clin. Neuromuscul. Dis."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719210003434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719210003434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T20:25:46Z","timestamp":1544214346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719210003434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1096719210003434"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2010.09.002","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}